Literature DB >> 29850040

Crystal structure of 4-(pyrazin-2-yl)morpholine.

Siva Sankar Murthy Bandaru1, Anant Ramakant Kapdi2, Carola Schulzke1.   

Abstract

The mol-ecular structure of the title compound, C8H11N3O, is nearly planar despite the chair conformation of the n class="Chemical">morpholine moiety. In the crystal, the mol-ecules form sheets parallel to the b axis, which are supported by non-classical hydrogen-bonding inter-actions between C-H functionalities and the O atom of morpholine and the 4-N atom of pyrazine, respectively. The title compound crystallizes in the monoclinic space group P21/c with four mol-ecules in the unit cell.

Entities:  

Keywords:  Buchwald–Hartwig amination; crystal structure; morpholine; palladium-catalysed reactions; pyrazine

Year:  2018        PMID: 29850040      PMCID: PMC5956323          DOI: 10.1107/S2056989018000312

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The potential applications of aryl and heteroaryl amines in chemistry, materials science and pharmaceutical industries encourages research into the formation of C—n class="Chemical">N bonds (Rappoport, 2007 ▸; Lawrence, 2004 ▸, Weissermel & Arpe 1997 ▸). N-Hetero­aryl­morpholine moieties are prevalent in biologically active mol­ecules such as medicines for the treatment of schizophrenia or type-2 diabetes mellitus (Bartolomé-Nebreda et al., 2014 ▸). In this context we are engaged in the synthesis of a library of heterocyclic amine derivatives. In course of these investigations, pure crystalline 4-(pyrazin-2-yl)morpholine was isolated with the crystals being obtained upon purification by column chromatography.

Structural commentary

4-(Pyrazin-2-yl)morpholine (Fig. 1 ▸) crystallizes in the monoclinic space group P21/c with four mol­ecules in the unit cell. There are reports in the literature of the mol­ecular structures of compounds in which the n class="Chemical">morpholine nitro­gen atom is coupled to the carbon atom of a non-annelated N-heterocyclic pyridine (Dahlgren et al., 2012 ▸; Horton et al., 2012 ▸; Huth et al., 2007 ▸; Klauschenz et al., 1994 ▸; Li et al., 2014 ▸, Reck et al., 1992 ▸) or pyrimidine (Cheprakova et al., 2014 ▸; García et al., 2009 ▸; Gorbunov et al., 2013 ▸; Hansen & Geffken, 2012 ▸; Vinogradova et al., 2016 ▸). For pyrazine as the heterocycle, however, (to the best of our knowledge and after conducting a database search, see §4) the present work constitutes the first structural report even though the title compound itself has been known since 1969 (Abe et al., 1969 ▸).
Figure 1

The mol­ecular structure of the title compound, showing the atom labelling and 50% probability displacement ellipsoids.

The orientation of the morpholine ring, in its typical chair conformation, relative to the aromatic plane can be either more or less in plane (e.g. Vinogradova et al., 2016 ▸), tilted around the n class="Chemical">N—C bond (e.g. Li et al., 2014 ▸), bent away from the aromatic plane (e.g. Hansen & Geffken, 2012 ▸) or a combination of the latter two (e.g. Reck et al., 1992 ▸), depending on the other substituents on the heterocycle. In the present case, a morpholine ring is as much aligned with the N1/N2/C1–C4 plane as its conformation allows, with the carbon C8 showing the largest distance from the plane of 0.414 (1) Å. This distance is shorter than for any of the pyridine or pyrimidine derivatives without morpholine disorder from the reports mentioned above. The largest deviation from the plane of the pyrizine atoms was found to be 0.013 (1) Å for C1 and C4. The quality of the crystallographic data allowed the hydrogen atoms to be located and refined entirely freely without any constraints or restraints. The information content of the metrical parameters involving the n class="Chemical">hydrogen atoms, including non-classical hydrogen-bonding inter­actions, is therefore comparably high. The C—H distances for the aromatic atoms are 0.999 (15) Å for C2, 0.976 (16) Å for C3 and 0.962 (16) Å for C4. The methyl­ene protons are in a distance range from their parent carbon atoms of 0.978 (14) to 1.016 (14) Å with a tendency for the longer C—H bond to be for the hydrogen atom in the axial position [only C7 is an exception with distances of 1.003 (14) Å for the axial and 1.005 (14) Å for the equatorial position]. All C—C, C—N and C—O bond lengths are within the commonly observed ranges.

Supra­molecular features

In the crystal, the mol­ecules form sheets parallel to the b axis supported by non-classical hydrogen-bonding inter­actions (Fig. 2 ▸, Table 1 ▸). In each mol­ecule, the n class="Chemical">pyrazine ring is tilted slightly out of the general orientation of the sheets and the direction of the rotation alternates between adjacent rows (protruding along the b axis) as well as between adjacent layers with an angle of 17.95° between the two variants of torsion.
Figure 2

The crystal packing (Mercury; Macrae et al., 2006 ▸) viewed (top) along the c axis and (bottom) along the b axis showing the layered arrangement and the non-classical hydrogen-bonding inter­actions (Table 1 ▸) between the mol­ecules of a sheet.

Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C6—H6A⋯O1i 0.988 (14)2.561 (14)3.4841 (16)155.5 (10)
C3—H3⋯N2ii 0.976 (16)2.670 (16)3.5723 (19)153.9 (13)
C2—H2⋯N2iii 0.999 (15)2.743 (15)3.6840 (19)157.2 (11)
C4—H4⋯N1iv 0.962 (16)2.787 (16)3.6775 (18)154.3 (11)

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

Within the sheets, each mol­ecule forms hydrogen-bonding interactions to six surrounding mol­ecules. These are n class="Species">donor inter­actions involving C2 [C2—H2⋯N2(x, y + 1, z)], C3 [C3—H3⋯N2(−x + 2, y + , −z + ], C4 [C4—H4⋯N1(x, y − 1, z)] and C6 [C6—H6A⋯O1(−x + 1, y + , −z + )] and acceptor inter­actions involving N1 [N1⋯H4—C4(x, y + 1, z)], N2 [N2⋯H2—C2(x, y − 1, z), N2⋯H3—C3(−x + 2, y + , −z + ] and O1 [O1⋯H6A—C6(1 − x,  + y,  − z)]. No π–π inter­actions are apparent between the sheets, with the closest distance between aromatic ring centroids being 4.2470 (11) Å while two sheets are 3.564 Å apart.

Synthesis and crystallization

The synthesis was carried out under an inert gas atmosphere (N2) applying the typical Schlenk line procedures. To an oven-dried Schlenk tube (25 mL) were added n class="Chemical">Pd(OAc)2 (1 mol%, 0.0024 g) and PTABS (phosphatriazene adamantyl butane saltone; 2 mol%, 0.00586 g) and a nitro­gen atmosphere was generated. To this were added 3 mL of dry DMF followed by the addition of 2-chloro­pyrazine (0.086 mL, 1mmol), 1.5 equivalents of tri­ethyl­amine (0.3 mL, 1.5 mmol) and 1.1 equivalent of morpholine (0.1 mL, 1.1 mmol). The suspension was stirred at room temperature for 4 h and progress of the reaction was monitored by TLC. After completion of the reaction, the crude product was purified and isolated by column chromatography in an EtOAc:hexane (1:3) solvent system. The final sharp colourless needles (0.124 mg, 0.83 mmol, 83%) were obtained directly after the column purification step by crystallizing from the eluent. The mounted crystal was a block cut from a large needle. The compound has a low melting point of only 318 K and the crystals were stored in the fridge until they were measured. 1H n class="Chemical">NMR (300 MHz, chloro­form-d) δ ppm 3.51–3.63 (m, 4 H), 3.79–3.90 (m, 4 H), 7.90 (d, J = 2.64 Hz, 1 H), 8.14 (d, J = 7.6Hz, 1 H), 9.61 (d, J = 7.8 Hz, 1 H). 13C NMR (75 MHz, chloro­form-d) δ ppm 45.18 (s, 1C) 66.93 (s, 1C) 77.42 (s, 1C) 77.84 (s, 1C) 131.33 (s, 1C) 133.98 (s, 1C) 142.16 (s, 1C) 155.48 (s, 1C). ESI–MS (m/z) = 166.17 (M + H)+, 167.22 (M + 2H)2+ (cf. Graham et al., 2011 ▸).

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. All hydrogen atoms were located and refined freely without any constraints or restraints.
Table 2

Experimental details

Crystal data
Chemical formulaC8H11N3O
M r 165.20
Crystal system, space groupMonoclinic, P21/c
Temperature (K)170
a, b, c (Å)17.069 (3), 5.9278 (12), 7.8053 (16)
β (°)90.54 (3)
V3)789.7 (3)
Z 4
Radiation typeMo Kα
μ (mm−1)0.10
Crystal size (mm)0.38 × 0.31 × 0.26
 
Data collection
DiffractometerStoe IPDS2T
No. of measured, independent and observed [I > 2σ(I)] reflections6583, 1666, 1285
R int 0.044
(sin θ/λ)max−1)0.634
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.032, 0.081, 1.01
No. of reflections1666
No. of parameters153
H-atom treatmentAll H-atom parameters refined
Δρmax, Δρmin (e Å−3)0.19, −0.18

Computer programs: X-AREA (Stoe & Cie, 2010 ▸), SHELXT2016 (Sheldrick, 2015a ▸), SHELXL2016 (Sheldrick, 2015b ▸), XP in SHELXTL (Sheldrick, 2008 ▸), Mercury (Macrae et al., 2006 ▸) and CIFTAB (Sheldrick, 2008 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989018000312/ds2249sup1.cif Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989018000312/ds2249Isup2.cml CCDC reference: 1585321 Additional supporting information: crystallographic information; 3D view; checkCIF report
C8H11N3OF(000) = 352
Mr = 165.20Dx = 1.389 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 17.069 (3) ÅCell parameters from 7070 reflections
b = 5.9278 (12) Åθ = 5.2–53.6°
c = 7.8053 (16) ŵ = 0.10 mm1
β = 90.54 (3)°T = 170 K
V = 789.7 (3) Å3Block, colourless
Z = 40.38 × 0.31 × 0.26 mm
Stoe IPDS2T diffractometer1285 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.044
Detector resolution: 6.67 pixels mm-1θmax = 26.8°, θmin = 3.6°
ω scansh = −21→21
6583 measured reflectionsk = −7→7
1666 independent reflectionsl = −9→9
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.032All H-atom parameters refined
wR(F2) = 0.081w = 1/[σ2(Fo2) + (0.0391P)2 + 0.1242P] where P = (Fo2 + 2Fc2)/3
S = 1.01(Δ/σ)max < 0.001
1666 reflectionsΔρmax = 0.19 e Å3
153 parametersΔρmin = −0.18 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
O10.56805 (5)0.49320 (14)0.28629 (10)0.0288 (2)
N10.80725 (6)0.78798 (17)0.57424 (13)0.0273 (2)
N20.91130 (6)0.4299 (2)0.62453 (16)0.0389 (3)
N30.71160 (5)0.53996 (16)0.47126 (12)0.0225 (2)
C10.78753 (7)0.57747 (19)0.53119 (14)0.0227 (3)
C20.87897 (7)0.8160 (2)0.64356 (18)0.0327 (3)
C30.93002 (8)0.6409 (2)0.66999 (19)0.0370 (3)
C40.84119 (7)0.4000 (2)0.55398 (17)0.0318 (3)
C50.66501 (6)0.73760 (19)0.42267 (15)0.0226 (3)
C60.57955 (7)0.6729 (2)0.40626 (15)0.0255 (3)
C70.61043 (7)0.3001 (2)0.34360 (16)0.0271 (3)
C80.69742 (7)0.3467 (2)0.35819 (15)0.0258 (3)
H6B0.5600 (7)0.621 (2)0.5203 (17)0.028 (3)*
H5B0.6834 (7)0.804 (2)0.3125 (16)0.023 (3)*
H5A0.6694 (7)0.853 (2)0.5118 (17)0.027 (3)*
H8B0.7235 (8)0.210 (3)0.4052 (17)0.031 (4)*
H7B0.5899 (7)0.248 (2)0.4570 (17)0.029 (3)*
H6A0.5487 (8)0.802 (2)0.3624 (16)0.028 (3)*
H40.8289 (8)0.248 (3)0.5193 (18)0.038 (4)*
H7A0.6002 (8)0.177 (2)0.2579 (17)0.028 (3)*
H8A0.7193 (8)0.380 (2)0.2402 (17)0.034 (4)*
H20.8931 (8)0.975 (3)0.6735 (17)0.035 (4)*
H30.9810 (9)0.670 (3)0.723 (2)0.049 (4)*
U11U22U33U12U13U23
O10.0287 (5)0.0263 (5)0.0310 (4)−0.0026 (4)−0.0104 (3)0.0010 (3)
N10.0217 (5)0.0252 (5)0.0348 (6)−0.0007 (4)−0.0041 (4)−0.0036 (4)
N20.0255 (6)0.0337 (6)0.0571 (7)0.0040 (5)−0.0100 (5)0.0021 (5)
N30.0200 (5)0.0191 (5)0.0283 (5)0.0005 (4)−0.0037 (4)−0.0012 (4)
C10.0199 (5)0.0240 (6)0.0242 (5)−0.0006 (4)0.0009 (4)0.0009 (4)
C20.0251 (6)0.0303 (7)0.0427 (7)−0.0023 (5)−0.0065 (5)−0.0042 (6)
C30.0219 (6)0.0382 (8)0.0507 (8)−0.0016 (6)−0.0094 (6)−0.0013 (6)
C40.0259 (6)0.0247 (6)0.0448 (7)0.0013 (5)−0.0057 (5)0.0011 (5)
C50.0215 (6)0.0212 (5)0.0251 (6)0.0003 (5)−0.0023 (4)0.0003 (5)
C60.0222 (6)0.0245 (6)0.0297 (6)−0.0005 (5)−0.0039 (5)0.0006 (5)
C70.0300 (6)0.0228 (6)0.0282 (6)−0.0044 (5)−0.0054 (5)0.0005 (5)
C80.0286 (6)0.0209 (6)0.0279 (6)0.0001 (5)−0.0024 (5)−0.0023 (5)
O1—C71.4238 (15)C3—H30.976 (16)
O1—C61.4307 (14)C4—H40.962 (16)
N1—C11.3345 (15)C5—C61.5126 (16)
N1—C21.3441 (16)C5—H5B0.999 (13)
N2—C41.3244 (16)C5—H5A0.978 (14)
N2—C31.3381 (18)C6—H6B1.002 (13)
N3—C11.3917 (15)C6—H6A0.988 (14)
N3—C51.4639 (15)C7—C81.5135 (17)
N3—C81.4648 (14)C7—H7B1.003 (14)
C1—C41.4051 (17)C7—H7A1.005 (14)
C2—C31.3693 (19)C8—H8B0.995 (15)
C2—H20.999 (15)C8—H8A1.016 (14)
C7—O1—C6109.07 (9)N3—C5—H5A109.7 (8)
C1—N1—C2116.31 (10)C6—C5—H5A107.7 (8)
C4—N2—C3116.61 (11)H5B—C5—H5A108.3 (10)
C1—N3—C5117.46 (9)O1—C6—C5111.74 (10)
C1—N3—C8118.39 (9)O1—C6—H6B108.0 (7)
C5—N3—C8112.55 (9)C5—C6—H6B109.3 (7)
N1—C1—N3117.76 (10)O1—C6—H6A106.3 (7)
N1—C1—C4120.38 (11)C5—C6—H6A110.1 (8)
N3—C1—C4121.79 (11)H6B—C6—H6A111.4 (10)
N1—C2—C3122.88 (12)O1—C7—C8111.85 (10)
N1—C2—H2115.3 (8)O1—C7—H7B110.0 (8)
C3—C2—H2121.9 (8)C8—C7—H7B109.9 (7)
N2—C3—C2121.23 (12)O1—C7—H7A106.9 (7)
N2—C3—H3119.1 (10)C8—C7—H7A110.3 (8)
C2—C3—H3119.7 (10)H7B—C7—H7A107.8 (11)
N2—C4—C1122.53 (12)N3—C8—C7110.14 (10)
N2—C4—H4115.9 (9)N3—C8—H8B110.2 (8)
C1—C4—H4121.6 (9)C7—C8—H8B108.3 (8)
N3—C5—C6109.88 (10)N3—C8—H8A109.6 (8)
N3—C5—H5B111.4 (7)C7—C8—H8A109.6 (8)
C6—C5—H5B109.7 (7)H8B—C8—H8A108.9 (11)
D—H···AD—HH···AD···AD—H···A
C6—H6A···O1i0.988 (14)2.561 (14)3.4841 (16)155.5 (10)
C3—H3···N2ii0.976 (16)2.670 (16)3.5723 (19)153.9 (13)
C2—H2···N2iii0.999 (15)2.743 (15)3.6840 (19)157.2 (11)
C4—H4···N1iv0.962 (16)2.787 (16)3.6775 (18)154.3 (11)
  11 in total

1.  A method for the reductive scission of heterocyclic thioethers.

Authors:  Thomas H Graham; Wensheng Liu; Dong-Ming Shen
Journal:  Org Lett       Date:  2011-11-08       Impact factor: 6.005

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  4,6-Diamino-2-morpholino-5-nitrosopyrimidine: a polarized molecular structure within hydrogen-bonded sheets.

Authors:  Angélica García; Braulio Insuasty; Justo Cobo; Christopher Glidewell
Journal:  Acta Crystallogr C       Date:  2009-11-07       Impact factor: 1.172

4.  Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia.

Authors:  José Manuel Bartolomé-Nebreda; Francisca Delgado; María Luz Martín-Martín; Carlos M Martínez-Viturro; Joaquín Pastor; Han Min Tong; Laura Iturrino; Gregor J Macdonald; Wendy Sanderson; Anton Megens; Xavier Langlois; Marijke Somers; Greet Vanhoof; Susana Conde-Ceide
Journal:  J Med Chem       Date:  2014-05-09       Impact factor: 7.446

5.  Copper-catalyzed carboxamide-directed ortho amination of anilines with alkylamines at room temperature.

Authors:  Qiong Li; Shu-Yu Zhang; Gang He; Zhaoyan Ai; William A Nack; Gong Chen
Journal:  Org Lett       Date:  2014-03-04       Impact factor: 6.005

6.  Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor.

Authors:  Markus K Dahlgren; Alvaro Baeza Garcia; Alissa A Hare; Julian Tirado-Rives; Lin Leng; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2012-10-26       Impact factor: 7.446

7.  [Potential cardiotonics. 16. Molecular and crystal structures of three polymorphic forms and a hydrochloride monohydrate of 3-cyano-2-morpholino-5-(pyridin-4-yl)pyridine (AWD 122-14)].

Authors:  G Reck; V Hagen; G Bannier
Journal:  Pharmazie       Date:  1992-11       Impact factor: 1.267

8.  2-(Morpholin-4-yl)-6-(1H-pyrrol-1-yl)-pyridine-3,5-dicarbonitrile.

Authors:  Peter N Horton; Shaaban K Mohamed; Ahmed M Soliman; Eman M M Abdel-Raheem; Mehmet Akkurt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-29

9.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

10.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.